tm logo
RETHINK ADHD SYMPTOM CONTROL
Live/Registered
REGISTERED

on 08 Mar 2022

Last Applicant/ Owned by

1550 East Gude Drive

Rockville

MD

20850

Serial Number

90287870 filed on 29th Oct 2020

Registration Number

6668162 registered on 08th Mar 2022

in the Principal Register

Correspondent Address

Mark Simpson

Mark Simpson

1500 MARKET STREET

CENTRE SQUARE WEST, 38TH FLOOR

PHILADELPHIA, PA 19102-2186

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

RETHINK ADHD SYMPTOM CONTROL

Pharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders


First Use Date in General

25th May 2021

First Use Date in Commerce

19th Jul 2021

Mark Details


Serial Number

No 90287870

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 356969.00062

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
08th Mar 2022REGISTERED-PRINCIPAL REGISTER
03rd Feb 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02th Feb 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
31st Jan 2022STATEMENT OF USE PROCESSING COMPLETE
28th Jan 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
13th Jan 2022USE AMENDMENT FILED
13th Jan 2022TEAS STATEMENT OF USE RECEIVED
13th Jul 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
18th May 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18th May 2021PUBLISHED FOR OPPOSITION